# Vivosens

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vivosens

- Industry: Software
- Headquarters: San Francisco, US
- Website: www.vivoo.io
- Total disclosed funding: $3.3M
- Latest round: Series A (Sep 20, 2021)
- Investors on record: 5

## About

Vivosens Inc. specializes in innovative at-home wellness testing, providing users with tools to monitor and enhance their health conveniently.Founded in 2017, Vivosens Inc. operates out of San Francisco, US, focusing on wellness testing products. The company was established by a team of founders including Amara R, George Radman, Gozde Buyukacaroglu, Marcel Mester, and Miray Tayfun, who also serves as CEO. In September 2021, Vivosens raised USD 3.30 mn in Series A funding, bringing its total amount raised to USD 3.30 mn with a current company valuation of USD 20.60 mn.Vivoo offers a range of innovative at-home wellness testing products designed to empower users in monitoring and improving their health. At the core of Vivoo's offerings is the Vivoo Wellness Test, a urine test that analyzes eight key health parameters: Vitamin C, Magnesium, Calcium, Sodium, Oxidative Stress, pH, Hydration, and Ketones. Utilizing a user-friendly mobile application, users can receive real-time insights and actionable advice tailored to their individual health needs. The primary end users include individuals looking to track their overall wellness, fertility, and hydration levels from the comfort of their homes. Vivoo's products are marketed in various international regions, including North America and Europe, catering to a diverse customer base that values convenient and accurate health assessments without the need for traditional laboratory visits.Vivoo generates revenue primarily through the direct-to-consumer sales model, offering its wellness tests and related services through its e-commerce platform. Customers can purchase individual tests or opt for subscription plans that provide regular testing at a discounted rate. The flagship Vivoo Wellness Test is priced competitively, promoting frequent use among health-conscious consumers. In addition to individual sales, Vivoo may explore partnerships with healthcare providers and wellness practitioners, allowing for broader distribution and enhanced customer engagement. The company's pricing structure supports accessibility and encourages ongoing health monitoring, fostering a consistent revenue stream from repeat users seeking proactive wellness management.In September 2021, Vivoo raised USD 3.30 mn in Series A funding, which will be utilized to expand its team and scale the business, with a particular focus on the US market. The company has already established partnerships with major retail outlets, including Amazon and Walmart, to distribute its products. Vivosens plans to enhance its product offerings and is looking to introduce new wellness tests in the upcoming year while expanding into new markets to increase its reach.

## Funding rounds

- Series A, Sep 20, 2021, $3.3M — Revo Capital, Halogen, Global Ventures, 500 Startups Canada, ONCE Ventures

## Investors

- Revo Capital (https://capitalatlas.ai/funds/revo-capital) — Series A
- Halogen (https://capitalatlas.ai/funds/halogen) — Series A
- Global Ventures (https://capitalatlas.ai/funds/global-ventures) — Series A
- 500 Startups Canada (https://capitalatlas.ai/funds/500-startups-canada) — Series A
- ONCE Ventures (https://capitalatlas.ai/funds/once-ventures) — Series A